Jane Street Group, LLC Valneva Se Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$13.71 - $37.57 $227,366 - $623,060	-16,584 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$27.0 - $50.99 $206,928 - $390,787	7,664 Added 85.92%	16,584 $569,000
Q4 2021 Feb 15, 2022	SELL	$27.1 - $67.28 $371,513 - $922,341	-13,709 Reduced 60.58%	8,920 $495,000
Q3 2021 Nov 16, 2021	SELL	$25.02 - $53.38 $30,674 - $65,443	-1,226 Reduced 5.14%	22,629 $711,000
Q2 2021 Aug 16, 2021	BUY	$24.41 - $31.04 $582,300 - $740,459	23,855 New	23,855 $629,000

683K

Ticker VALN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,103,504
Market Cap $386M
Description
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.